Godavari Drugs clarifies on price movement; no undisclosed info

Godavari Drugs Ltd responded to a BSE query dated April 17, 2026, regarding significant movement in its share price. The company stated that it has complied with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by making all necessary and timely disclosures of price-sensitive information. Godavari Drugs confirmed that it is not aware of any undisclosed price-sensitive information that would be required to be intimated to the stock exchanges. The company attributed the movement in its share price entirely to market conditions, over which it has no control.